Cargando…
It is time to consider third-line options in antiretroviral-experienced paediatric patients?
BACKGROUND: The historic use of full-dose ritonavir as part of an unboosted protease inhibitor (PI)-based antiretroviral therapy regimen in some South African children contributes to the frequent accumulation of major PI resistance mutations. METHODS: In order to describe the prevalence of major PI...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228719/ https://www.ncbi.nlm.nih.gov/pubmed/22085598 http://dx.doi.org/10.1186/1758-2652-14-55 |